You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 東陽光藥(1558.HK)續跌6%再創調整新低 遭調出港股通+投行看淡
格隆匯 09-08 13:45
格隆匯9月8日丨東陽光藥(1558.HK)延續下跌行情,續跌6%,3日連跌12%,自7月以來股價跌幅超40%。現報4.83港元再度刷新調整新低價,總市值不足45億港元。東陽光藥遭調出港股通,並於週一(6日)起生效。大摩下調公司目標價至5.8港元,評級“與大市同步”。主要下調治療及預防流感抗病毒藥物可威(Kewei)的銷售額預測;中金公司日前稱,公司核心產品持續受創,1H21業績不達預期,下調公司評級為中性,大幅下調目標價45.5%至6港元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account